TFF PHARMACEUTICALS, INC.

Profile

Company Names

TFF PHARMACEUTICALS, INC.

Addresses

1751 RIVER RUN, SUITE 400, FORT WORTH, TX 76107

2600 VIA FORTUNA, SUITE 360, AUSTIN, TX 78746

2801 VIA FORTUNA, SUITE 425, AUSTIN, TX 78746

Phone Numbers

817-438-6168
737-802-1979

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$48,238,560.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2024-03-22 
$0.00 
$1,180,000.00 
$1,180,000.00 
 
3
2020-08-10 
$25,913,560.00 
$25,913,560.00 
$0.00 
Equity 
2
2019-05-16 
$8,170,000.00 
$8,170,000.00 
$0.00 
Equity 
1
2018-03-13 
$14,155,000.00 
$14,155,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KIRK 
 
COLEMAN 
EXECUTIVE OFFICER
TFF PHARMACEUTICALS, INC.
MALCOLM 
 
FAIRBAIRN 
DIRECTOR
ASCEND PARTNERS FUND I LP   |  ASCEND PARTNERS FUND II LP   |  ASCEND WILSON FUND LP   |  ASCEND CL FUND, LTD.   |  ASCEND CL FUND LP   |  ASCEND LEGEND FUND LP   |  ASCEND LEGEND FUND, LTD.   |  ASCEND CN FUND LP   |  ASCEND AC FUND LP   |  ASCEND ERSRI FUND LP   |  ASCEND PARTNERS FUND LP   |  TFF PHARMACEUTICALS, INC.
AARON 
 
FLETCHER 
DIRECTOR
LUNG THERAPEUTICS, INC.   |  COGNITION THERAPEUTICS INC   |  BIOS LTI SPV II, LP   |  TFF PHARMACEUTICALS, INC.   |  ABILITECH MEDICAL, INC.   |  XY GAMING, INC.   |  CUE BIOPHARMA, INC.   |  BIOS SPECIAL OPPORTUNITY FUND II, LP   |  ACTUATE THERAPEUTICS, INC.   |  ONL THERAPEUTICS, INC.
THOMAS 
 
KING 
DIRECTOR
THERMASOURCE LLC   |  ACHAOGEN INC   |  ENERGYSAVVY INC   |  FARADAY PHARMACEUTICALS, INC.   |  CONCENTRIC ANALGESICS, INC.   |  SATSUMA PHARMACEUTICALS, INC.   |  LIMIVOROUS PREFERRED FUND LP   |  TFF PHARMACEUTICALS, INC.   |  BLACK ICE DATA INC.
CATHERINE 
 
LEE 
DIRECTOR
BERGAMOT SPECIAL SITUATIONS FUND I L.P.   |  ATP FUND 6 SOPHIE 2017, LP   |  ATP FUND 7 GIORGETTI 2017, LP   |  OMNIOME, INC.   |  TFF PHARMACEUTICALS, INC.
GLENN 
 
MATTES 
EXECUTIVE OFFICER, DIRECTOR
ADVANTAGENE, INC.   |  CORNOVUS PHARMACEUTICALS INC.   |  VIKING SCIENTIFIC, INC.   |  TFF PHARMACEUTICALS, INC.
ZAMANEH 
 
MIKHAK 
EXECUTIVE OFFICER
TFF PHARMACEUTICALS, INC.
ROBERT 
S. 
MILLS, JR. 
DIRECTOR, EXECUTIVE OFFICER
TFF PHARMACEUTICALS, INC.
MICHAEL 
 
PATANE 
DIRECTOR
EYEGATE PHARMACEUTICALS INC   |  TFF PHARMACEUTICALS, INC.
BRANDI 
 
ROBERTS 
DIRECTOR
TFF PHARMACEUTICALS, INC.
STEPHEN 
 
ROCAMBOLI 
DIRECTOR
FORESIGHT BIOTHERAPEUTICS, INC.   |  TFF PHARMACEUTICALS, INC.
RANDY 
 
THURMAN 
DIRECTOR
TFF PHARMACEUTICALS, INC.   |  OUTLOOK THERAPEUTICS, INC.
HARLAN 
 
WEISMAN 
EXECUTIVE OFFICER, DIRECTOR
INTELLIRAD CONTROL, INC.   |  CONTROLRAD SYSTEMS, INC.   |  CONTROLRAD, INC.   |  TFF PHARMACEUTICALS, INC.   |  FLAME BIOSCIENCES, INC.
BRIAN 
 
WINDSOR 
EXECUTIVE OFFICER, DIRECTOR
TFF PHARMACEUTICALS, INC.   |  LUNG THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-04-02
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2024-03-22 
2020-08-19
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-08-10 
2019-07-24
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-05-16 
2018-03-27
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-13 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NONE
NONE
JEFFERIES LLC
2347
NONE
NONE
NATIONAL SECURITIES CORPORATION
7569